Source: Pharmabiz

SeraCare: SeraCare Life Sciences introduces gDNA & FFPE reference materials for tumour mutational burden measurement assay

SeraCare Life Sciences, part of the LGC Clinical Diagnostics Business Unit and a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, announced the commercial release of the first ever genomic DNA

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Michael Sweatt's photo - General Manager of SeraCare

General Manager

Michael Sweatt

CEO Approval Rating

82/100

Read more